Produkty 143442-54-0

CAS 143442-54-0 występuje w naszej ofercie pod nazwami: 9(S)-HODE cholesteryl ester, 9(S)–HODE cholesteryl ester. Oferty producentów: TargetMol, GLPBio, MedChemExpress. Dostępne opakowania: 25ug, 50ug, 100ug, 100μg, 25μg, 50μg, 25 μg, 50 μg.

9(S)-HODE cholesteryl ester
TargetMol, MedChemExpress
  • opakowanie: 25ug, 50ug, 100ug, 25 μg
  • Warianty: 5
od 1763,98
Zobacz produkt
9(S)–HODE cholesteryl ester
GLPBio
  • opakowanie: 100μg, 25μg, 50μg
  • Warianty: 3
od 1430,17
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9S,10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate (CAS 143442-54-0) to związek chemiczny o wzorze sumarycznym C45H76O3 i masie molowej 665.1 g/mol. Nazwa systematyczna IUPAC: [(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9S,10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate. InChIKey: ALWABJCAEDQEGO-OTHQBIEFSA-N.

Dane identyfikacyjne
Wzór sumarycznyC45H76O3
Masa molowa665.1 g/mol
Nazwa IUPAC[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9S,10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate
InChIKeyALWABJCAEDQEGO-OTHQBIEFSA-N
SMILESCCCCC/C=C\C=C/[C@H](CCCCCCCC(=O)O[C@H]1CC[C@@]2([C@H]3CC[C@]4([C@H]([C@@H]3CC=C2C1)CC[C@@H]4[C@H](C)CCCC(C)C)C)C)O

Dane obliczone przez PubChem (NCBI)

Synonimy: 9(S)-HODE cholesteryl ester, 9S-hydroxy-10E,12Z-octadecadienoic acid, cholesteryl ester
Powiązane formy tego związku
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9R,10E,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9R,10Z,12Z)-9-hydroxyoctadeca-10,12-dienoate C45H76O3
Izomery (ten sam wzór sumaryczny)
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,11E)-13-hydroxyoctadeca-9,11-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9E,11E,13R)-13-hydroxyoctadeca-9,11-dienoate C45H76O3
[(3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoate C45H76O3